Home › Funds › Vanguard Group › IMPLQ
Vanguard Group position in IMPLQ
IMPEL PHARMACEUTICALS INC
Latest position (Q3 2023)505.23K sh
Reported value held$217.25K
Portfolio Weight0.00%
First reportedQ2 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2021 | 183.75K | $1.63M | New |
| Q3 2021 | 364.54K | $4.44M | Add |
| Q4 2021 | 491.75K | $4.24M | Add |
| Q1 2022 | 531.78K | $3.39M | Add |
| Q2 2022 | 513.87K | $4.79M | Reduce |
| Q3 2022 | 513.87K | $2.50M | Hold |
| Q4 2022 | 514.07K | $1.93M | Hold |
| Q1 2023 | 514.07K | $719.70K | Hold |
| Q2 2023 | 507.88K | $645.00K | Reduce |
| Q3 2023 | 505.23K | $217.25K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IMPLQ
No other tracked fund reports a position in IMPLQ.